Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02686073
Other study ID # Kasr El-Aini Hospital
Secondary ID
Status Completed
Phase N/A
First received February 7, 2016
Last updated July 10, 2017
Start date February 20, 2016
Est. completion date February 28, 2017

Study information

Verified date July 2017
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Study the rate of progress of labor among nulliparous women belonging to different body mass index groups, & observe how does this variation in maternal body mass index may affect the course of labor.


Description:

For nulliparous cases presenting to the labor ward, maternal height & weight will be collected at the time of admission to calculate the BMI (body mass index) & further classified according to WHO (World Health Organization) categories. Putting into consideration the physiological increase in BMI related to pregnancy, the overweight participants whose BMI (25-29.9) will be combined with the normal range BMI (18.5-24.9) category. Labor characteristics of these participants will be then compared with those of the underweight (BMI less than 18.5) & obese (BMI 30 or higher) participants.Females are assigned in one of 3 groups based on their BMI; Underweight group (BMI <18.5kg/m2), Control group whose BMI within normal range (18.5-29.9 kg/m2),& Obese group (BMI more than or equal 30kg/m2).

Labor management protocols are fixed. Data on labor progression are collected, including cervical dilatation, cervical effacement, head station & descent. The median duration of labor , estimated by rate of cervical dilatation in cm, will be used as a measurement of labor progression in each group.

A cesarean section for abnormal labor pattern will be documented as failure of progress.


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date February 28, 2017
Est. primary completion date February 28, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- nulliparous women in active phase of labor, with an age range from 20 to 40 years.

Full term pregnancy, singleton, viable fetus, cephalic (vertex) presentation, occipito-anterior position.

Exclusion Criteria:

- Multiparous women. Preterm labor. Passed date delivery. Multiple gestation. Large fetal weight (more than 4000g). Intrauterine fetal death. Intrauterine fetal growth restriction. Major fetal congenital anomalies. Rupture of membranes before onset of active labor. Fetal malposition or malpresentation. Inadequate pelvis or cephalopelvic disproportion. Maternal medical disorder.

Induction of labor by oxytocin or prostaglandins. Conditions requiring urgent delivery eg antepartum haemorrhage, fetal distress, cord prolapse.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Cairo University Cairo Greater Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other duration of active phase of labor total duration in hours all through the course of labor, individually assessed for each participant, starting from the time of admission to labor ward until start of second stage of labor
Other duration of second stage of labor total duration in minutes from start of second stage of labor ( full cervical dilatation) until delivery of fetus
Other mode of delivery vaginal delivery or cesarean section labor
Primary rate of cervical dilatation in centimeters every 2 hours during active phase of labor, from admission to the labor ward until second stage of labor.
Secondary descent of fetal head head station every 2 hours during active phase of labor, from admission to the labor ward until second stage of labor
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06403982 - The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia N/A